Khoa Công nghệ sinh học & CNTP
Thông tin tuyển sinh 2019
WEBSITE CÁC ĐƠN VỊ
Trang chủ Nghiên cứu
14/04/2014 22:11 - Xem: 1137

The EFEMP1 Gene: A Frequent Target for Epigenetic Silencing in Multiple Human Pituitary Adenoma Subtypes

Background/Aims: In a genome-wide investigation we recently identified the EGF-containing fibulin-like extracellular matrix protein 1 gene, EFEMP1, as hypermethylated in growth hormone-secreting adenoma.

Background/Aims: In a genome-wide investigation we recently identified the EGF-containing fibulin-like extracellular matrix protein 1 gene, EFEMP1, as hypermethylated in growth hormone-secreting adenoma. Methods: In an independent cohort we determined expression of EFEMP1, CpG island methylation and histone tail modification status. The causal consequences of epigenetic modification were determined through epidrug-induced reversal and enforced EFEMP1 expression in GH3 cells. Results: The majority of adenomas, irrespective of subtype, show reduced EFEMP1 expression. However, epigenetic change, as determined by CpG island methylation, was not invariantly associated with decreased EFEMP1 expression. Conversely, chromatin immunoprecipitation assays revealed enrichment for modifications associated with either active or silenced genes in adenoma that did or did not express EFEMP1 respectively. In AtT-20 and GH3 cells a causal relationship between epigenetic silencing and expression of EFEMP1 was established where co-incubation with the epidrugs zebularine and TSA induced expression of EFEMP1 and concomitant histone tail  modifications toward those associated with expressed genes. Enforced expression of EFEMP1 in GH3 cells was without effect on cell proliferation or apoptotic end-points, however inhibition of endogenous matrix metalloproteinase (MMP2) expression was apparent. Primary adenomas did not show this relationship, however a positive correlation was apparent with the MMP7 transcript and perhaps reflects cell or species differences. Conclusions:The protein product of the EFEMP1 gene, fibulin-3, is reported to impact on multiple pathways in a cell-specific context. Subtype-independent loss of EFEMP1 expression in the majority of primary adenomas should prompt more detailed investigation in this tumour type.

Full-text available at http://www.karger.com/Article/FullText/355624

Attention please contact the author by emai duongvancuong@tuaf.edu.vn

CÁC BÀI VIẾT CÙNG CHUYÊN MỤC
Web các đơn vị
Thông tin tuyển sinh 2019
Đang online 12356
Hôm nay 9252
Hôm qua 17069
Tuần này 9252
Tuần trước 162931
Tháng này 2866442
Tháng trước 3024524
Tất cả 34184544

Lượt truy cập: 34184611

Đang online: 12406

Ngày hôm qua: 17069

online

Chào mừng bạn đến với hệ thống trả lời hỗ trợ trực tuyến.
Để liên hệ với các bộ phận xin vui lòng điền đầy đủ vào mẫu kết nối

Họ và tên


Địa chỉ Email


Yêu cầu hỗ trợ